How many insider declarations has CAI Sui Xiong filed?

CAI Sui Xiong has filed 3 public insider declarations with HKEX.

What is CAI Sui Xiong's role?

CAI Sui Xiong's reported role is not specified by the regulator across the filings.

Which companies does CAI Sui Xiong report trades for?

CAI Sui Xiong reports trades for IMPACT Therapeutics, Inc - B - H Shares.

← Executives ★ Sign in to follow

CS

CAI Sui Xiong

OFFICER

·HKEX

IMPACT Therapeutics, Inc - B - H Shares

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by CAI Sui Xiong. Director active across 1 company, notably IMPACT Therapeutics, Inc - B - H Shares. In total, 3 reports have been published. Activity tracked since 1 September 2026. The latest transaction was disclosed on 1 September 2026 (Purchase). Regulator: HKEX. All data is free.

Companies and markets linked to CAI Sui Xiong

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

IMPACT Therapeutics, Inc - B - H Shares (HK)

申报3 总计

●

CAI Sui Xiong

Director高管2026年9月1日IMPACT Therapeutics, Inc - B - H Shares

HK$146万0HKEX ↗

100,000 股@ HK$14.6105ShareXHKGHKEX:DA20260903E00086

●

CAI Sui Xiong

Director高管2026年6月10日IMPACT Therapeutics, Inc - B - H Shares

0HKEX ↗

18,440,884 股ShareXHKGHKEX:DA20260618E00018

●

CAI Sui Xiong

Director高管2026年5月13日IMPACT Therapeutics, Inc - B - H Shares

0HKEX ↗

18,440,884 股ShareXHKGHKEX:DA20260522E00324

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

CS

CAI Sui Xiong

OFFICER

·HKEX

IMPACT Therapeutics, Inc - B - H Shares

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by CAI Sui Xiong. Director active across 1 company, notably IMPACT Therapeutics, Inc - B - H Shares. In total, 3 reports have been published. Activity tracked since 1 September 2026. The latest transaction was disclosed on 1 September 2026 (Purchase). Regulator: HKEX. All data is free.